The incredible leaps in technology that now make high-speed genome sequencing possible are revolutionizing the hunt for genes and genetic variations associated with disease. A stunning series of recent genome-wide association studies (GWAS) have identified new candidate genes for a number of common diseases including breast cancer, heart disease, diabetes type I and II, obesity, Crohn's disease, multiple sclerosis, glaucoma, and asthma. This Genomics Select highlights several of the most recent GWAS and also explores how a genome-wide approach can be used to address intriguing questions in cell and molecular biology.
contributed by the two interleukin receptor variants is low, this work does open up new avenues for elucidating the pathogenesis of this disease.
These studies, together with more than 15 others, provide a big step forward in identifying unsuspected genes and their variants associated with a number of common diseases. However, an even bigger challenge will be to convert these tantalizing genetic insights into a firm understanding of disease pathogenesis enabling the identification of new therapeutic targets and the development of new treatments. H. Hakonarson et al. (2007) . Nature 448, 591; J.A. Todd et al. (2007) . Nat. Genet. 39, 857; N.J. Samani et al. (2007) . N. Engl. J. Med. 357, 443; D.F. Gudbjartsson et al. (2007) . Nature 448, 353; D.A. Hafler et al. (2007) . N. Engl. J. Med. 10.1056/NEJM0a073493; G. Thorleifsson et al. (2007) . Science. 10.1126/science.1146554. 
Parthenogenesis under Wraps
An unusual application of genome-wide SNP analysis is reported by Daley and colleagues (Kim et al., 2007) , who use this approach to prove that a human embryonic stem (ES) cell line was derived by parthenogenesis instead of somatic cell nuclear transfer (SCNT). Human ES cell lines are usually derived from excess embryos generated by in vitro fertilization, but they can also be produced by SCNT, in which a nucleus from a mature somatic cell is inserted into a donor oocyte that has had its own nucleus removed. SCNT has been touted as a viable method for producing patient-specific human ES cells, although, to date, claims of success have proven to be erroneous. A third method for generating human ES cell lines that has received less attention is parthenogenesis, which involves artificial activation of an oocyte in the absence of fertilization, resulting in development of an embryo based entirely on the maternal genome. Daley and colleagues apply genome-wide SNP analysis to elucidate whether a human ES cell line (SCNT-hES-1) claimed to have been generated by SCNT could instead have been derived by parthenogenesis. The authors demonstrate convincingly that the patterns of SNP homozygosity and heterozygosity in SCNT-hES-1 cells are very similar to those of mouse ES cell lines known to have been derived parthenogenetically. They next examined the methylation status of differentiated SCNT-hES-1 cells at three imprinted gene loci, one normally methylated on the paternal genome and the other two normally methylated on the maternal genome. They show that the two maternally imprinted loci were fully methylated indicative of the SCNT-hES-1 cells having two maternal genomes, whereas the paternally imprinted locus was predominantly unmethylated, suggesting a missing paternal genome. Together, these data demonstrate that the SCNT-hES-1 cell line claimed to be generated by SCNT was in fact produced through parthenogenetic development of the donor oocyte, which had retained its nucleus during the SCNT procedure. The approach of Daley and coworkers could be applied in the future to discern the correct origin of human ES cell lines generated using the same donor for both the oocyte and the somatic cell nucleus. The authors also propose that parthenogenetically derived human ES cell lines might provide a useful source of tissue for research and perhaps even transplantation as long as such tissues that lack methylation of paternally imprinted genes prove to be functional and free of growth abnormalities. K. Kim et al. (2007 ). Cell Stem Cell. 10.1016 /j.stem.2007 
Chromatin Profiling Made Easy
A key characteristic of ES cells is that they can be induced to leave their pluripotent state and differentiate into one of many different cell lineages. Each of the steps along the lineage commitment pathway is believed to reflect a different chromatin state regulated by a suite of modifications (most notably methylation) to histones and other proteins. Now Mikkelsen et al. (2007) apply a clever method to derive detailed genome-wide maps of the distribution of chromatin modifications in three mouse stem cell lines at different stages of lineage commitment. The method (ChIP-Seq) combines chromatin immunoprecipitation (ChIP) of DNA with single molecule sequencing using a high-speed Illumina/ Solexa sequencer to map ChIP enrichment. The authors examined five different methylation patterns of histone H3 and H4 in mouse ES cells, neural progenitor cells, and embryonic fibroblasts and obtained genome-wide chromatin distribution maps for each pattern in each cell type. They found that particular patterns of trimethylation of H3 and H4 lysine residues could be used as markers to identify, for example, primary coding and noncoding transcripts (trimethylation of H3 lysine 36) or repetitive elements (trimethylation of lysine 9 in H3 and lysine 20 in H4). Importantly, a bivalent marker (trimethylation of H3 lysines 4 and 27) seemed to reflect retention of pluripotency, with loss of the bivalent mark associated with differentiation. These genome-wide maps of chromatin state yield insights into gene expression potential and cell differentiation state that go beyond information obtained by more traditional methods such as RNA expression profiling. T.S. Mikkelsen et al. (2007) . Nature 448, 553.
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A human ES cell line (SCNT-hES-1) derived by parthenogenesis. Photo courtesy of G. Lee, J.-H. Shieh, and M. Moore.
